Literature DB >> 29657546

Successful pregnancy outcome using sperm from severely diseased men with testicular cancer and collagen disease: Three case reports.

Sachiko Sasaki1, Keiko Sasaki1, Sayaka Takahashi1, Toshie Sasaki1, Koichi Kyono1, Yasuhisa Araki2.   

Abstract

Objective:  To confirm the feasibility of using fresh or frozen/thawed spermatozoa from cancer and collagen diseased patients for intracytoplasmic sperm injection (ICSI). Patients:  Two participants were diagnosed with testicular carcinoma and one patient was diagnosed with collagen disease.
Methods:   Of the two carcinoma patients, one patient provided a fresh testicular biopsy sample and one patient ejaculated fresh sperm after surgical operation. One collagen diseased patient's sperm was frozen, and three samples were used in subsequent ICSI treatment cycles. Their female partners underwent controlled ovarian hyperstimulation for the retrieval of oocytes.
Results:   Two patients with testicular cancer and their respective partners achieved successful pregnancies from ICSI using fresh sperm after surgery. The patient suffering from collagen disease had a successful pregnancy from ICSI using sperm frozen prior to chemotherapy treatment. Conclusions:  Patients with testicular carcinoma or collagen disease who might desire to father children in the future should be offered sperm preservation prior to the initiation of chemotherapy treatment. Under currently available treatment, patients with cases of severe disease can still become biological fathers. (Reprod Med Biol 2004; 3: 69-75).

Entities:  

Keywords:  azoospermia; cryopreservation; intracytoplasmic sperm injection; malignant disease

Year:  2004        PMID: 29657546      PMCID: PMC5891734          DOI: 10.1111/j.1447-0578.2004.00055.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  21 in total

1.  The human testis--an organ at risk?

Authors:  A Giwercman; N E Skakkebaek
Journal:  Int J Androl       Date:  1992-10

2.  Vitrification of mouse and human blastocysts using a novel cryoloop container-less technique.

Authors:  M Lane; W B Schoolcraft; D K Gardner
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

3.  Efficiency of using frozen-thawed testicular sperm for multiple intracytoplasmic sperm injections.

Authors:  N Fukunaga; K Haigo; K Kyono; Y Araki
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

Review 4.  Human aneuploidy: incidence, origin, and etiology.

Authors:  T Hassold; M Abruzzo; K Adkins; D Griffin; M Merrill; E Millie; D Saker; J Shen; M Zaragoza
Journal:  Environ Mol Mutagen       Date:  1996       Impact factor: 3.216

5.  Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection.

Authors:  M N Damani; V Master; M V Meng; C Burgess; P Turek; R D Oates; V Masters
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

Review 6.  Genetic and teratogenic effects of cancer treatments on gametes and embryos.

Authors:  J Arnon; D Meirow; H Lewis-Roness; A Ornoy
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

Review 7.  Culture and selection of viable blastocysts: a feasible proposition for human IVF?

Authors:  D K Gardner; M Lane
Journal:  Hum Reprod Update       Date:  1997 Jul-Aug       Impact factor: 15.610

8.  Pregnancy achieved following ICSI from a man with Klinefelter's syndrome and spinal cord injury.

Authors:  K Kyono; N Fukunaga; K Haigo; S Chiba; Y Araki
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

9.  Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy.

Authors:  M Meseguer; N Garrido; J Remohí; A Pellicer; C Simón; J M Martínez-Jabaloyas; M Gil-Salom
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

Review 10.  Effects of chemotherapy and radiotherapy on spermatogenesis.

Authors:  M L Meistrich
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.